|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
nan
|
|
gptkbp:advertising
|
nan
|
|
gptkbp:awards
|
Various industry awards
|
|
gptkbp:businessModel
|
Diversified portfolio
|
|
gptkbp:CEO
|
gptkb:Glenn_Saldanha
|
|
gptkbp:challenges
|
Market competition
Regulatory hurdles
Pricing pressures
|
|
gptkbp:clinicalTrials
|
Yes
|
|
gptkbp:collaborations
|
Various academic institutions
|
|
gptkbp:community_engagement
|
Yes
|
|
gptkbp:employees
|
Over 10,000
|
|
gptkbp:exportMarkets
|
gptkb:Asia
gptkb:India
gptkb:USA
Europe
|
|
gptkbp:financialPerformance
|
Consistent growth
Listed on stock exchanges
|
|
gptkbp:founded
|
1977
|
|
gptkbp:founder
|
gptkb:Glenmark_Pharmaceuticals
|
|
gptkbp:future_plans
|
Innovation and growth
Positive growth prospects
|
|
gptkbp:global_presence
|
Yes
|
|
gptkbp:governance
|
Yes
|
|
gptkbp:headquarters
|
gptkb:Mumbai
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Glenmark Pharmaceuticals Ltd.
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:investmentFocus
|
Yes
Significant investments in R&D
|
|
gptkbp:market
|
$3 billion (2021)
|
|
gptkbp:market_segment
|
Prescription drugs
Biosimilars
OTC products
|
|
gptkbp:operates_in
|
Over 80 countries
|
|
gptkbp:partnerships
|
Various global pharmaceutical companies
|
|
gptkbp:patentCitation
|
Numerous patents filed
|
|
gptkbp:philanthropy
|
Yes
|
|
gptkbp:productionLocation
|
Facilities in other countries
Multiple_facilities_in_India
|
|
gptkbp:products
|
Branded drugs
Active pharmaceutical ingredients (APIs)
Generic_drugs
|
|
gptkbp:regulatoryCompliance
|
Yes
|
|
gptkbp:research
|
nan
|
|
gptkbp:research_areas
|
Cardiology
Oncology
Diabetes
Dermatology
Respiratory
Multiple research centers globally
|
|
gptkbp:researchAndDevelopment
|
Yes
|
|
gptkbp:revenue
|
$1.2 billion (2021)
|
|
gptkbp:stockExchange
|
gptkb:BSE
NSE
|
|
gptkbp:subsidiary
|
gptkb:Glenmark_Generics_Ltd.
gptkb:Glenmark_Life_Sciences
|
|
gptkbp:sustainability_initiatives
|
Yes
|
|
gptkbp:targetMarket
|
Regular product launches
|
|
gptkbp:territory
|
Yes
|
|
gptkbp:website
|
www.glenmarkpharma.com
|